The connection between depression and diabetes is a complex and often overlooked issue, but it's time to shed light on this critical aspect of patient care. The impact of these comorbid conditions can be devastating, and pharmacists have a crucial role to play in managing this tricky interplay.
Diabetes and depression, though seemingly unrelated, share an intricate relationship. With nearly 12% of the US population affected by diabetes and a little under 9% by depression, the overlap between these conditions is significant. The risk of developing one increases with the presence of the other, creating a challenging cycle for patients and healthcare providers alike.
But here's where it gets controversial... While the statistics are eye-opening, the true impact lies in the complications that arise from treating these conditions simultaneously. Pharmacists, with their expertise, are in a unique position to navigate this complex landscape and provide integrated care.
Kathleen M. Vest, PharmD, and Sarah E. Grady, PharmD, presented at the ASHP Midyear 2025, highlighting the need for a patient-centric approach to break this cycle of poor health. Their argument? Integrated care is the key to managing the bidirectional relationship between diabetes and depression.
Navigating the Complex Web: Diabetes and Depression
People living with chronic diseases, such as diabetes, are at an increased risk of developing depression. This can be triggered by the stress of managing their illness or the side effects of medications. Vest, a certified diabetes care specialist, emphasizes that individuals with diabetes are twice as likely to experience depression compared to those without diabetes.
Vest further explains how the symptoms of depression can overlap with those of diabetes. Using the mnemonic M SIG E CAPS, she illustrates the signs and symptoms of depression, which include changes in mood, sleep, interest, guilt, energy levels, concentration, appetite, psychomotor function, and suicidal thoughts. A diagnosis of depression requires at least five of these symptoms, and it's crucial to note that many patients with diabetes may exhibit some of these signs as part of their diabetes-related complications.
And this is the part most people miss... The treatment of diabetes, especially with glucagon-like peptide-1 (GLP-1) medications, can further complicate matters. These medications may cause weight loss, which can be misinterpreted as a symptom of depression. Vest highlights how this overlap can make it challenging to accurately diagnose and treat both conditions.
Furthermore, depression can significantly impact a patient's ability to manage their diabetes. Lack of energy, sleep disturbances, and loss of interest can hinder their motivation to monitor glucose levels and administer insulin. This creates a vicious cycle where the treatment of one condition may inadvertently affect the other.
The Challenges of Comorbidity: A Double-Edged Sword
For patients with depression, antidepressants come with a set of challenges. These medications can cause weight gain, stimulate appetite, and increase caloric intake, especially carbohydrate consumption, which directly impacts glucose levels. Grady emphasizes that long-term use of antidepressants has been linked to the development of diabetes, but it also reduces mortality in patients with type 2 diabetes (T2D).
Grady also highlights the complexity of treating patients with a history of substance use disorder. Antipsychotics, commonly prescribed for behavioral health issues, can detrimentally impact glucose levels. Additionally, selective serotonin reuptake inhibitors (SSRIs) may cause pancreatic cell dysfunction, leading to insulin release issues and hypoglycemia, especially when administered with sulfonylureas.
The Pharmacist's Role: A Patient-Centric Approach
Grady and Vest stress the importance of a patient-centric treatment plan. For patients with either diabetes or depression, or both, pharmacists should regularly screen for the other condition and closely monitor the impact of medications on the patient's overall health and quality of life.
Vest shares an example from her practice, where patients who tried GLP-1 agonists experienced negative side effects. Some patients find comfort and improved mood through food, and restricting this can have unintended consequences. Grady's clinic prescribes GLP-1 agonists alongside antipsychotics to mitigate the weight gain associated with the latter, ensuring a full risk-benefit discussion with the patient.
The two pharmacists emphasize the need for collaboration across specialties. By breaking down silos and combining expertise, they aim to provide concurrent treatment for the best possible outcomes. Integrated care is the key to managing the complex relationship between depression and diabetes, and pharmacists have a vital role in making this a reality.
